Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia

被引:164
作者
Pan, ZJ
vanderHulst, RWM
Feller, M
Xiao, SD
Tytgat, GNJ
Dankert, J
vanderEnde, A
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT MED MICROBIOL, NL-1100 DE AMSTERDAM, NETHERLANDS
[2] UNIV AMSTERDAM, ACAD MED CTR, DEPT GASTROENTEROL, NL-1100 DE AMSTERDAM, NETHERLANDS
[3] SHANGHAI MED UNIV 2, SHANGHAI INST DIGEST DIS, SHANGHAI, PEOPLES R CHINA
关键词
D O I
10.1128/JCM.35.6.1344-1347.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Approximately 60% of Helicobacter pylori isolates in the Western world possess the cytotoxin-associated gene A (cagA). cagA-positive H. pylori is found to be associated with peptic ulcer disease (PUD) and gastric adenocarcinoma. To investigate the cagA status of H. pylori isolates from Chinese patients with PUD and chronic gastritis (CG), H. pylori populations from 83 patients, 48 with PUD and 35 with CG, were assessed by two different cagA-specific PCRs, Southern blotting, and colony hybridization. The combined results from PCR, Southern blotting, and colony hybridization indicate a prevalence of cagA-positive H. pylori isolates of 98% (47 of 48) among Chinese PUD patients and 100% (35 of 35) among Chinese CG patients, Amplification with primer sets 1 and 2 yielded 52 and 95% of the 82 cagA-positive Chinese H. pylori, respectively, In contrast, the sensitivity of cagA-specific PCR for cagA-positive H. pylori isolates from Dutch patients with primer set 1 was 92% (112 of 122) and that with primer set 2 was 91% (50 of 55). The prevalence of cagA-positive H. pylori populations in Chinese patients,with PUD and CG is almost universally high, Therefore, cagA cannot be used as a marker for the presence of PUD in Chinese patients, Our data further suggest that allelic variation in cagA may exist and that distinct H. pylori genotypes may circulate in China and Western Europe.
引用
收藏
页码:1344 / 1347
页数:4
相关论文
共 28 条
[1]  
APEL I, 1988, ZBL BAKT-INT J MED M, V268, P271
[2]   MOLECULAR CHARACTERIZATION OF THE 128-KDA IMMUNODOMINANT ANTIGEN OF HELICOBACTER-PYLORI-ASSOCIATED WITH CYTOTOXICITY AND DUODENAL-ULCER [J].
COVACCI, A ;
CENSINI, S ;
BUGNOLI, M ;
PETRACCA, R ;
BURRONI, D ;
MACCHIA, G ;
MASSONE, A ;
PAPINI, E ;
XIANG, ZY ;
FIGURA, N ;
RAPPUOLI, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5791-5795
[3]   SEROLOGIC DETECTION OF INFECTION WITH CAGA(+) HELICOBACTER-PYLORI STRAINS [J].
COVER, TL ;
GLUPCZYNSKI, Y ;
LAGE, AP ;
BURETTE, A ;
TUMMURU, MKR ;
PEREZPEREZ, GI ;
BLASER, MJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (06) :1496-1500
[4]   CHARACTERIZATION OF AND HUMAN SEROLOGIC RESPONSE TO PROTEINS IN HELICOBACTER-PYLORI BROTH CULTURE SUPERNATANTS WITH VACUOLIZING CYTOTOXIN ACTIVITY [J].
COVER, TL ;
DOOLEY, CP ;
BLASER, MJ .
INFECTION AND IMMUNITY, 1990, 58 (03) :603-610
[5]   EXPRESSION OF 120 KILODALTON PROTEIN AND CYTOTOXICITY IN HELICOBACTER-PYLORI [J].
CRABTREE, JE ;
FIGURA, N ;
TAYLOR, JD ;
BUGNOLI, M ;
ARMELLINI, D ;
TOMPKINS, DS .
JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (08) :733-734
[6]   MUCOSAL IGA RECOGNITION OF HELICOBACTER-PYLORI 120-KDA PROTEIN, PEPTIC-ULCERATION, AND GASTRIC PATHOLOGY [J].
CRABTREE, JE ;
TAYLOR, JD ;
WYATT, JI ;
HEATLEY, RV ;
SHALLCROSS, TM ;
TOMPKINS, DS ;
RATHBONE, BJ .
LANCET, 1991, 338 (8763) :332-335
[7]   HELICOBACTER-PYLORI AND PEPTIC-ULCERATION - HISTOPATHOLOGICAL ASPECTS [J].
DIXON, MF .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1991, 6 (02) :125-130
[8]   PREVALENCE OF HELICOBACTER-PYLORI INFECTION AND HISTOLOGIC GASTRITIS IN ASYMPTOMATIC PERSONS [J].
DOOLEY, CP ;
COHEN, H ;
FITZGIBBONS, PL ;
BAUER, M ;
APPLEMAN, MD ;
PEREZPEREZ, GI ;
BLASER, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (23) :1562-1566
[9]  
FOREMAN D, 1993, LANCET, V341, P359
[10]   IDENTIFICATION OF CAMPYLOBACTER-PYLORIDIS ISOLATES BY RESTRICTION ENDONUCLEASE DNA ANALYSIS [J].
LANGENBERG, W ;
RAUWS, EAJ ;
WIDJOJOKUSUMO, A ;
TYTGAT, GJN ;
ZANEN, HC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (03) :414-417